2021 Webinar: Challenges in NASH Clinical Trials

Create Account

Availability

On-Demand

Cost

$0.00

Credit Offered

No Credit Offered

Description
Summary
Recommended

Join the Nonalcoholic Fatty Liver Disease Special Interest Group in discussing the current challenges in histological assessment in NASH clinical trials. Presenters will also discuss how to implement hard outcomes in NASH clinical trials and the use non-invasive biomarkers as primary endpoints for drug approval.

Webinar hosted by the Nonalcoholic Fatty Liver Disease Special Interest Group on May 19, 2021.

Fundamentals of Liver Disease - All Courses

Multiple Credits

FREE

2024 Webinar: Priorities and Barriers to Achieve Hepatitis C Elimination in the United States

No Credit

FREE

2024 Webinar Enduring: World Hepatitis Day – 2024: AASLD - INASL Joint Webinar on Viral Hepatitis

No Credit

FREE

The Liver Meeting 2022

FREE

2021 Webinar: Genetics of NAFLD

No Credit

FREE

2021 Webinar: NASH as a Cause of Hepatocellular Carcinoma

No Credit

FREE

2021 Webinar: Cardiovascular Disease in NASH Patients

No Credit

FREE

2019 Webinar: Liquid Biopsy in Hepatocellular Carcinoma: Applications in Surveillance and Prediction of Treatment Response

No Credit

FREE